13th Romtransplant Congress 2024: “Advancing Transplantation in Romania – Celebrating long-term sustainability and innovations”

October 8-9, 2024, Bucharest, Romania

General Overview:
The 13th Romtransplant Congress 2024 was a true success, uniting national and
internationally renowned experts who made significant contributions to the
field of transplantation. The event welcomed 274 participants and featured 67
speakers from 11 countries: Switzerland, France, Italy, the United Kingdom, the
Netherlands, the Republic of Moldova, Romania, Serbia, Spain, Sweden, and
Hungary. Of these, 17 were distinguished international speakers who brought
valuable global perspectives.

 

The congress was structured into 8 main sessions, 3 state-of-the-art conferences, 57 expert-led presentations, and 20 e-posters. Additionally, 3 industry symposia provided engaging platforms for discussing innovative technologies and transplant management solutions.

Key Highlights of the Event:

  1. Notable Contributions from ESOT Speakers and Close Collaboration:
    • The congress proudly featured significant participation from ESOT experts, highlighting the strong collaboration between Romtransplant and ESOT.
    • Gabriel Oniscu, President of ESOT, opened with the impactful State of the Art Conference “General ESOT Presentation: ‘What’s in it for you'”, showcasing the benefits and opportunities ESOT offers to its members and emphasizing the importance of continuous development in transplantation.
    • Chloë Ballesté (Barcelona, Spain) delivered essential training on donation after circulatory death (DCD), illustrating Spain’s leading position in organ donation since 1998.
    • Frank Dor (Rotterdam, Netherlands) shared insights on kidney donation in living donor programs, underlining how these initiatives enhance transplant success and patient quality of life.
    • Jelena Stojanovic (London, UK) provided a compelling presentation on improving renal transplant outcomes in children with end-stage renal disease, addressing the unique challenges faced by this vulnerable group.
    • Umberto Cillo (Padova, Italy) discussed the role of liver transplantation in oncology, presenting cases that extend beyond traditional criteria such as hepatocellular carcinoma, colorectal metastases, and cholangiocarcinoma.
    • Luciano Potena (Bologna, Italy) highlighted essential criteria for cardiac transplant assessments, focusing on innovative diagnostic and patient management approaches.
    • Xavier Charmetant (Lyon, France) shared groundbreaking insights into graft rejection immunology, suggesting novel strategies for prevention and treatment.
    • Ekaterine Berishvili (Geneva, Switzerland) explored the future of organ transplantation with organ cell therapy, presenting transformative potential in the field.
  2. Cardiac Transplantation and Leadership by Prof. Horațiu Moldovan:
    • Horațiu Moldovan, President of Romtransplant, played a pivotal role in chairing key cardiac transplantation sessions. Discussions included topics such as innovations in myocardial protection and advances in cardiac transplantation techniques, fostering an in-depth understanding of current challenges and opportunities in the field.
  3. Renal Transplantation and Coordination Sessions:
    • The congress featured robust sessions on renal transplantation, including case studies and long-term patient management strategies. Notably, the coordination session highlighted the evolving practices in organ procurement and transplant logistics, emphasizing multidisciplinary cooperation for optimal outcomes.
  4. Sessions Overview:
    • The sessions covered a wide array of topics in transplantation, with a strong focus on multidisciplinary collaboration involving specialties such as Cardiovascular Surgery, General Surgery, Pediatrics, Hepatology – Gastroenterology, Anesthesia, Radiology, Nephrology, Urology, Hematology
  5. State-of-the-Art Conferences:
    • Captivating lectures, including “Intestinal and Multivisceral Transplantation: Surgical Perspectives” by Hector Vilca-Melendez (Birmingham, UK), provided advanced surgical approaches and insights into complex post-transplant challenges.
  6. Industry Symposia:
    • Key symposia from Boston Scientific, Getinge, and Astellas underscored the latest technological advancements and best practices for long-term transplant management.
  7. Participation of Multidisciplinary Teams:
    • Contributions from experienced teams, particularly the Fundeni Clinical Institute led by Academician Prof. Dr. Irinel Popescu, showcased 25+ years of experience and stimulated discussions on current achievements and ongoing challenges.

Learning Objectives and Outcomes Achieved:
The congress reaffirmed its status as a premier platform for advancing transplantation knowledge, fostering collaboration, and sharing practical solutions. The event’s comprehensive approach to multidisciplinary care aimed at improving patient outcomes and highlighted innovative research and practices.

Key Takeaways:
The 13th Romtransplant Congress 2024 underscored the essential nature of integrated and interdisciplinary efforts in transplantation, featuring pioneering discussions that set the stage for future progress and enhanced patient care. This congress solidified its commitment to pushing the boundaries of transplant science and practice, with the collaborative spirit and expertise of ESOT members being instrumental in this endeavor.
The 13th Romtransplant Congress 2024 was a landmark event, strengthening professional relationships, inspiring innovation, and laying the groundwork for continued advancement in transplantation medicine.

CELE MAI RECENTE ȘTIRI

CELE MAI RECENTE ȘTIRI

APPR

Cei mai mulți pacienți nu cunosc simptomele CANCERULUI de PANCREAS

21 noiembrie 2024

EVENIMENT

NEWS IN GASTROENTEROLOGY 8-9 Noiembrie 2024 Cluj-Napoca

NEWS IN GASTROENTEROLOGY 8-9 Noiembrie 2024 Cluj-Napoca a fost oportunitatea perfecta pentru a ne reconecta si …

13 noiembrie 2024

WEBINAR

Va invităm să participați la primul webinar organizat de SRGH

Vom discuta principalele probleme ale inițierii și monitorizării terapiei cu Bulevirtide la pacienții cu hepatită și …

11 noiembrie 2024